SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
 

For the month of October, 2017

Commission File Number 1565025

 

 

AMBEV S.A.
(Exact name of registrant as specified in its charter)
 

AMBEV S.A.
(Translation of Registrant's name into English)
 

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil
(Address of principal executive office)
 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 


Form 20-F ___X___ Form 40-F _______

  Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

Yes _______ No ___X____


 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In September 2017:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

 

(   ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Company Name: Ambev S.A.

Name: Ambev S.A.

CPF/CNPJ: 07.526.557/0001-00

Qualification: Outstanding  Shares in Treasury

Initial Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

Shares

Common

10,032,272

0.0638

0.0638

Transac tions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day

Quantity

Price

Volume (R$) (3)

Shares

Common

Direct with the Company

Conversion in ADRs

06

4,236

0.00

0.00

Shares

Common

Direct with the Company

Conversion in ADRs

07

5,816

0.00

0.00

Shares

Common

Direct with the Company

Conversion in ADRs

08

8,481

0.00

0.00

Shares

Common

Direct with the Company

Conversion in ADRs

12

17,061

0.00

0.00

Shares

Common

Direct with the Company

Conversion in ADRs

15

5,445

0.00

0.00

Shares

Common

Direct with the Company

Conversion in ADRs

25

20,575

0.00

0.00

 

 

 

Total Conversion ADRs (Out)

 

61,614

 

0.00

Shares

Common

Direct with the Company

Exerc Options

01

16,877

5.138373

86,720.32

Shares

Common

Direct with the Company

Exerc Options

01

52,575

1.092840

57,456.06

Shares

Common

Direct with the Company

Exerc Options

01

107,925

1.296480

139,922.60

Shares

Common

Direct with the Company

Exerc Options

01

71,150

3.120960

222,056.30

Shares

Common

Direct with the Company

Exerc Options

01

34,950

17.198000

601,070.10

Shares

Common

Direct with the Company

Exerc Options

01

79,590

17.840000

1,419,885.60

Shares

Common

Direct with the Company

Exerc Options

04

95,210

11.972000

1,139,854.12

Shares

Common

Direct with the Company

Exerc Options

06

30,125

9.359600

281,957.95

Shares

Common

Direct with the Company

Exerc Options

13

51,502

9.359600

482,038.12

Shares

Common

Direct with the Company

Exerc Options

13

33,764

11.972000

404,222.61

Shares

Common

Direct with the Company

Exerc Options

14

19,415

17.198000

333,899.17

Shares

Common

Direct with the Company

Exerc Options

21

46,000

3.120960

143,564.16

Shares

Common

Direct with the Company

Exerc Options

21

30,125

9.359600

281,957.95

Shares

Common

Direct with the Company

Exerc Options

21

45,700

11.972000

547,120.40

 

 

 

Total Sell

 

714,908

 

6,141,725.46

 

 

 

 

 

 

 

 

Shares

Common

Direct with the Company

Plan of Shares Acquisition

01

231,650

18.31

4,241,511.50

Shares

Common

Direct with the Company

Plan of Shares Acquisition

01

102,276

19.76

2,020,973.76

Shares

Common

Direct with the Company

Plan of Shares Acquisition

04

5,100

19.73

100,623.00

Shares

Common

Direct with the Company

Plan of Shares Acquisition

06

14,007

20.13

281,960.91

Shares

Common

Direct with the Company

Plan of Shares Acquisition

13

41,845

21.18

886,277.10

Shares

Common

Direct with the Company

Plan of Shares Acquisition

14

15,758

21.19

333,912.02

Shares

Common

Direct with the Company

Plan of Shares Acquisition

21

121,825

21.36

2,602,182.00

Shares

Common

Direct with the Company

Plan of Shares Acquisition

28

10,043

21.06

211,505.58

 

 

 

Total Buy

 

542,504

 

10,678,945.87

Final Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

Shares

Common

9,798,254

0.0623

0.0623

                       

(1)       When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2)       Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3)       Quantity multiplied by price .


 

 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In September 2017:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

 

(  ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Company Name: Ambev S.A.

Name: Ambev S.A.

CPF/CNPJ: 07.526.557/0001-00

Qualification: Outstanding  Shares in Treasury

Initial Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

ADR (*)

Common

0

0.0000

0.0000

Transac tions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day

Quantity

Price USD

Volume (USD) (3)

 

 

 

 

 

 

 

 

ADR (*)

Common

Direct with the Company

Conversion in ADRs

06

4,236

0.00

0.00

ADR (*)

Common

Direct with the Company

Conversion in ADRs

07

5,816

0.00

0.00

ADR (*)

Common

Direct with the Company

Conversion in ADRs

08

8,481

0.00

0.00

ADR (*)

Common

Direct with the Company

Conversion in ADRs

12

17,061

0.00

0.00

ADR (*)

Common

Direct with the Company

Conversion in ADRs

15

5,445

0.00

0.00

ADR (*)

Common

Direct with the Company

Conversion in ADRs

25

20,575

0.00

0.00

 

 

 

Total Conversion ADRs (In)

 

61,614

 

0.00

 

 

 

 

 

 

 

 

ADR (*)

Common

Direct with the Company

Plan of Shares Acquisition

06

6,239

6.45

40,240.76

ADR (*)

Common

Direct with the Company

Plan of Shares Acquisition

07

34,634

6.46

223,737.04

ADR (*)

Common

Direct with the Company

Plan of Shares Acquisition

08

52,194

6.43

335,605.56

ADR (*)

Common

Direct with the Company

Plan of Shares Acquisition

12

5,714

6.68

38,170.90

ADR (*)

Common

Direct with the Company

Plan of Shares Acquisition

15

200,565

6.81

1,365,846.30

 

 

 

Total Buy

 

299,346

 

2,003,600.56

 

 

 

 

 

 

 

 

ADR (*)

Common

Direct with the Company

Exerc Options

06

10,475

3.841600

40,240.76

ADR (*)

Common

Direct with the Company

Exerc Options

07

40,450

5.531200

223,737.04

ADR (*)

Common

Direct with the Company

Exerc Options

08

60,675

5.531200

335,605.56

ADR (*)

Common

Direct with the Company

Exerc Options

12

22,775

1.676000

38,170.90

ADR (*)

Common

Direct with the Company

Exerc Options

15

206,010

6.630000

1,365,846.30

ADR (*)

Common

Direct with the Company

Exerc Options

25

20,575

1.248396

25,685.75

 

 

 

Total Sell

 

360,960

 

2,029,286.31

 

 

 

 

 

 

 

 

Final Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

ADR (*)

Common

0

0.0000

0.0000

                       

 

(1)       When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2)       Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3)       Quantity multiplied by price .

(*)    Each ADR is equivalent to 1 (one) share.


 

 

 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In September 2017:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

 

(  ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Subsidiary Name: Ambev Luxembourg S.À.R.L.

Qualification: Position – Total Return Swap

Transac tions in the month

Securities / Derivatives

Securities Characteristics (1)

Intermediary

Operation

Day (*)

Quantity (**)

Price USD

Volume (USD) (2)

Swap

Swap referenced in Shares

N/A

Total Return Swap Conclusion

04 (*)

2,363,200

19.7085

46,575,127.20

Swap

Swap referenced in Shares

N/A

Total Return Swap Conclusion

05 (*)

1,098,300

19.7490

21,690,326.70

Swap

Swap referenced in Shares

N/A

Total Return Swap Conclusion

27 (*)

1,411,700

20.9785

29,615,348.45

 

 

 

Total operation

 

4,873,200

 

97,880,802.35

 

(1)       Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

 

(2)       Quantity multiplied by price .

 

 

(*) In accordance with the Circular Letter/CVM/SEP/Nº07/2017, date information of the total return swap conclusion and not the date of the financial settlement of the transaction.

 

(**) The reported quantity is not actually related to a purchase or sale, but an economic exposure arising from the conclusion of a swap agreement on a consolidated basis, in accordance with the Circular Letter/CVM/SEP/Nº07/2017.

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Date: October 10, 2017
     
 
AMBEV S.A.
     
 
By: 
/s/ Ricardo Rittes de Oliveira Silva
 
Ricardo Rittes de Oliveira Silva
Chief Financial and Investor Relations Officer
 
 
 
 

Ambev (NYSE:ABEV)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Ambev Charts.
Ambev (NYSE:ABEV)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Ambev Charts.